Becker Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.26M | Sell |
37,281
-1,204
| -3% | -$115K | 0.1% | 112 |
|
|
2025
Q4 | $3.72M | Sell |
38,485
-1,634
| -4% | -$159K | 0.11% | 113 |
|
|
2025
Q3 | $3.85M | Sell |
40,119
-1,096
| -3% | -$101K | 0.11% | 114 |
|
|
2025
Q2 | $3.62M | Sell |
41,215
-2,231
| -5% | -$189K | 0.11% | 112 |
|
|
2025
Q1 | $3.93M | Sell |
43,446
-23,643
| -35% | -$2.12M | 0.13% | 111 |
|
|
2024
Q4 | $5.41M | Buy |
67,089
+23,812
| +55% | +$2.06M | 0.18% | 94 |
|
|
2024
Q3 | $3.93M | Sell |
43,277
-319,380
| -88% | -$26.9M | 0.13% | 115 |
|
|
2024
Q2 | $28.8M | Sell |
362,657
-16,979
| -4% | -$1.39M | 0.99% | 36 |
|
|
2024
Q1 | $33.3M | Buy |
379,636
+3,909
| +1% | +$334K | 1.15% | 31 |
|
|
2023
Q4 | $31.2M | Sell |
375,727
-4,297
| -1% | -$327K | 1.13% | 30 |
|
|
2023
Q3 | $30M | Sell |
380,024
-7,864
| -2% | -$658K | 1.19% | 27 |
|
|
2023
Q2 | $34.4M | Buy |
387,888
+3,831
| +1% | +$330K | 1.3% | 21 |
|
|
2023
Q1 | $31.2M | Buy |
384,057
+27,202
| +8% | +$2.22M | 1.23% | 26 |
|
|
2022
Q4 | $27.7M | Buy |
356,855
+43,867
| +14% | +$3.56M | 1.29% | 29 |
|
|
2022
Q3 | $25.3M | Buy |
312,988
+7,297
| +2% | +$656K | 1.33% | 25 |
|
|
2022
Q2 | $27.4M | Buy |
305,691
+4,982
| +2% | +$505K | 1.32% | 28 |
|
|
2022
Q1 | $33.4M | Buy |
300,709
+84,981
| +39% | +$8.98M | 1.35% | 23 |
|
|
2021
Q4 | $22.3M | Buy |
215,728
+5,323
| +3% | +$616K | 0.88% | 49 |
|
|
2021
Q3 | $26.4M | Buy |
210,405
+4,516
| +2% | +$585K | 1.11% | 37 |
|
|
2021
Q2 | $25.6M | Buy |
205,889
+3,233
| +2% | +$406K | 1.08% | 39 |
|
|
2021
Q1 | $23.9M | Buy |
202,656
+2,724
| +1% | +$319K | 1.08% | 38 |
|
|
2020
Q4 | $23.4M | Buy |
199,932
+4,162
| +2% | +$458K | 1.16% | 35 |
|
|
2020
Q3 | $20.3M | Buy |
195,770
+431
| +0.2% | +$43.3K | 1.13% | 36 |
|
|
2020
Q2 | $17.9M | Buy |
195,339
+189,320
| +3,145% | +$18.2M | 1.01% | 40 |
|
|
2020
Q1 | $543K | Sell |
6,019
-55
| -0.9% | -$5.85K | 0.03% | 123 |
|
|
2019
Q4 | $689K | Buy |
6,074
+500
| +9% | +$54.9K | 0.02% | 123 |
|
|
2019
Q3 | $605K | Hold |
5,574
| – | – | 0.02% | 120 |
|
|
2019
Q2 | $543K | Sell |
5,574
-154
| -3% | -$14.1K | 0.02% | 124 |
|
|
2019
Q1 | $522K | Hold |
5,728
| – | – | 0.02% | 134 |
|
|
2018
Q4 | $521K | Buy |
5,728
+454
| +9% | +$42.4K | 0.02% | 123 |
|
|
2018
Q3 | $519K | Sell |
5,274
-154
| -3% | -$14.2K | 0.02% | 133 |
|
|
2018
Q2 | $465K | Sell |
5,428
-709
| -12% | -$59.2K | 0.02% | 122 |
|
|
2018
Q1 | $492K | Buy |
+6,137
| New | +$506K | 0.02% | 125 |
|
|
2016
Q4 | – | Sell |
-2,615
| Closed | -$226K | – | 143 |
|
|
2016
Q3 | $226K | Buy |
2,615
+101
| +4% | +$8.8K | 0.01% | 130 |
|
|
2016
Q2 | $218K | Sell |
2,514
-1,071
| -30% | -$86.6K | 0.01% | 128 |
|
|
2016
Q1 | $269K | Buy |
3,585
+905
| +34% | +$68.2K | 0.01% | 112 |
|
|
2015
Q4 | $206K | Buy |
+2,680
| New | +$202K | 0.01% | 131 |
|
|
2015
Q2 | – | Sell |
-3,614
| Closed | -$282K | – | 143 |
|
|
2015
Q1 | $282K | Buy |
+3,614
| New | +$274K | 0.01% | 120 |
|
Other funds holding MDT
VCM
VPM
Becker Capital Management's MDT Position: Q1 2026 in Review
Becker Capital Management reduced its Medtronic (MDT) stake by 3.1% in Q1 2026, selling an estimated $115K and leaving 37,281 shares worth $3.26M. The position accounts for 0.1% of the portfolio, ranked #112.
Becker Capital Management first reported a position in MDT in Q1 2015 and has held it in 38 quarters since. The position peaked at $34.4M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Becker Capital Management held 37,281 shares of Medtronic worth $3.26M as of Q1 2026.
- Becker Capital Management sold 1,204 Medtronic shares in Q1 2026, an estimated $115K.
- Medtronic made up 0.1% of Becker Capital Management's portfolio in Q1 2026, its #112 holding.
- Becker Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 38 quarters since.
- Becker Capital Management's Medtronic position peaked at $34.4M in Q2 2023.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.